BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation (NYSE:MIL), a provider of technologies, tools and services for the global life science industry, is supporting an executive order signed by President Barack Obama at the White House today, which rescinds limits on federal funding of stem cell research. Millipore is a leading provider of stem cell products to the biomedical research community.
